SandRidge Mississippian Trust (SDT) Financials Nov
Post# of 250602
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for SandRidge Mississippian Trust
Fiscal year is January-December. All values USD millions. 2010 2011 2012 2013 5-year trend
Sales/Revenue - - 57.52M 78.99M 65.46M
Cost of Goods Sold (COGS) incl. D&A - - 1.75M 3.29M 3.08M
COGS excluding D&A - - 1.75M 3.29M 3.08M
Depreciation & Amortization Expense - - 0 - -
Depreciation - - 0 0 0
Amortization of Intangibles - - 0 0 0
Gross Income - - 55.77M 75.7M 62.38M
2010 2011 2012 2013 5-year trend
SG&A Expense - - 643,000 1.49M 1.35M
Research & Development - - 0 0 -
Other SG&A - - 643,000 1.49M 1.35M
Other Operating Expense - - 1.88M 616,000 1.51M
Unusual Expense - - - 0 0
EBIT after Unusual Expense - - - 0 0
Non Operating Income/Expense - - 0 11.01M 4.19M
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) - - 0 - 0
Interest Expense - - 0 0 0
Gross Interest Expense - - 0 0 0
Interest Capitalized - - 0 0 0
Pretax Income - - 53.24M 84.6M 63.71M
Income Tax - - 0 0 0
Income Tax - Current Domestic - - 0 - -
Income Tax - Current Foreign - - 0 - -
Income Tax - Deferred Domestic - - 0 - -
Income Tax - Deferred Foreign - - 0 - -
Income Tax Credits - - 0 - -
Equity in Affiliates - - 0 0 0
Other After Tax Income (Expense) - - 0 (920,000) 0
Consolidated Net Income - - 53.24M 83.68M 63.71M
Minority Interest Expense - - 0 0 0
Net Income - - 53.24M 83.68M 63.71M
Extraordinaries & Discontinued Operations - - 0 0 0
Extra Items & Gain/Loss Sale Of Assets - - 0 0 0
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations - - 0 0 0
Net Income After Extraordinaries - - 53.24M 83.68M 63.71M
Preferred Dividends - - 441,000 0 0
Net Income Available to Common - - 52.8M 83.68M 63.71M
EPS (Basic) - - 1.89 2.99 2.28
Basic Shares Outstanding - - 28M 28M 28M
EPS (Diluted) - - 1.89 2.99 2.28
Diluted Shares Outstanding - - 28M 28M 28M
EBITDA - - 53.24M - -
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.